Rankings
▼
Calendar
REVB Q1 2023 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
REVB
Revelation Biosciences, Inc.
$2M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$6,263
Operating Income
-$2M
Net Income
$6M
EPS (Diluted)
$942.76
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$32,095
Balance Sheet
Total Assets
$18M
Total Liabilities
$8M
Stockholders' Equity
$10M
Cash & Equivalents
$18M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$6,263
-$21,222
+70.5%
Operating Income
-$2M
-$7M
+75.4%
Net Income
$6M
-$7M
+193.1%
← FY 2023
All Quarters
Q2 2023 →